Epigeneron logo — company profile

Epigeneron

Founded 2015 Series B Total: $368.00M Biotechnology, Manufacturing

General Information

Company Name Epigeneron
Founded Year 2015
Industries Biotechnology, Manufacturing
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Epigeneron. To contact Epigeneron, visit epigeneron.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Epigeneron compare?

A PDF of Epigeneron and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Epigeneron soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Epigeneron

Epigeneron is a biotechnology and manufacturing startup founded in 2015. The company recently secured a ¥48.00M Series B investment on 11 March 2021 from 東北大学ベンチャーパートナーズ株式会社. This funding marks a significant milestone for the company, as it continues to develop innovative solutions in the biotechnology and manufacturing industries. As Epigeneron advances with its cutting-edge technologies, this latest investment is expected to propel the company towards further growth and success in the competitive market.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B ¥48.00M 1
東北大学ベンチャーパートナーズ株式会社
11 Mar 2021
Series B ¥320.00M 2
The University of Tokyo Edge Capital, Toshiba Corporation
17 Sep 2020
Venture Round Undisclosed 1
The University of Tokyo Edge Capital
12 Mar 2018

FAQ About Epigeneron

Epigeneron was founded in 2015.
Epigeneron operates in Biotechnology and Manufacturing.
Epigeneron has completed 3 funding rounds, raising a total of $368.00M. The latest funding stage is Series B.

We're actively collecting intelligence on Epigeneron.

Source: BounceWatch company record for Epigeneron, https://bouncewatch.com/company/epigeneron, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes